Life
Replimune's Skin Cancer Drug Faces Another FDA Rejection
Replimune's cancer drug candidate has been rejected by the FDA for the second time, raising questions and discussions within the medical community.
editorial-staff 1 day ago
3 articles tagged with "drug approval"
Replimune's cancer drug candidate has been rejected by the FDA for the second time, raising questions and discussions within the medical community.
Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary.
Strategic implications in focus: Recent FDA decisions could complicate the Trump administration's relationship with drugmaker UniQure.